2023's Breakthroughs in Addiction Medicine: Key Findings from ASAM
Episode Overview
Buprenorphine initiation strategies for high-potency synthetic opioids
Alcohol intake's impact on all-cause mortality risk
Factors contributing to rising opioid overdose deaths among Black Americans
Leveraging the opioid ecosystem to reduce addiction and overdose
Innovative community pharmacy-led buprenorphine initiation protocol
The experience of opioid withdrawal negatively impacts the success of buprenorphine treatment, and attention to withdrawal management before and during buprenorphine initiation should be proactive.
What were the game-changing discoveries in addiction medicine this past year? This episode of 'This Week in Addiction Medicine' brings you the highlights from ASAM Weekly's top publications of 2023. The episode dives into pivotal studies that have influenced the field, offering a comprehensive look at advancements in treating opioid use disorder, particularly with buprenorphine for those using high-potency synthetic opioids. It emphasizes the importance of personalized treatment plans, managing withdrawal symptoms, and considering novel drug components in patient care.
Whether you're a healthcare professional, a student, or someone affected by addiction, this episode is packed with essential insights that can inform and improve treatment strategies.